Menu
Not yet recruiting NCT07677761

Manual Lymphatic Drainage on Pressure Injuries

No phase Interventional Pressure Injuries MANUEL LENFATIK DRENAJ

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Experimental, Control.
Who it may be relevant to
Registry conditions: Pressure Injuries, MANUEL LENFATIK DRENAJ. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Effect of Manual Lymphatic Drainage on Pressure Injuries: A Pilot Study Example

Overview

Pressure injuries are a significant health problem, often resulting from pressure, friction, and impaired tissue perfusion, and are particularly common in individuals in intensive care, those with immobility, and those with chronic diseases. The literature extensively addresses interventions such as pressure reduction, the use of appropriate support surfaces, wound care practices, and nutritional support in the prevention and treatment of pressure injuries. However, the role of manual therapies aimed at improving circulation and lymphatic flow, such as manual lymphatic drainage (MLD), in pressure injuries has been examined in a limited number of studies. This research aims to fill a significant gap in the literature by evaluating the potential effects of manual lymphatic drainage on reducing edema, improving tissue perfusion, and supporting the wound healing process in individuals with pressure injuries.

Interventions

  • Other Experimental
    Individuals will be randomly assigned to intervention and control groups in a 1:1 ratio via the website random.org. The Bates-Jensen Wound Assessment Tool will be administered to all individuals by the researchers. The size of the wound (length\*depth\*width) will be measured and recorded. Standard care will be applied to the control group. The experimental group will receive standard care along with manual lymphatic drainage according to the protocol below. Afterwards, the Bates-Jensen Wound As
  • Other Control
    Standard care practices will include regular position changes for patients, use of supportive surfaces to reduce pressure, maintenance of skin integrity, and keeping the wound area clean. Wound cleaning will be performed with sterile solutions, appropriate debridement methods will be applied in the presence of necrotic tissue, and suitable dressing materials will be selected according to the condition of the wound bed. In addition, patients' nutritional status, hydration level, and signs of infe

Primary outcome measures

  • Effect of manual lymphatic drainage [Time frame: 3 months]

Eligibility criteria

Inclusion criteria

  • Presence of pressure injury in the sacrum region
  • Volunteer to participate in the study
  • Being over 18 years of age
  • Being hospitalized in the anesthesia intensive care unit

Exclusion criteria

  • Chronic illness that may affect pressure injury healing (malnutrition, hypertension, and diabetes)
  • Discharge during the investigation process
  • Death during the investigation process
  • Acute cellulitis
  • Severe heart failure
  • Renal failure
  • Tuberculosis
  • Superior vena cava obstruction

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Crossover
Masking
Open label
Primary purpose
Health services research

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07677761 · Pressure Injury - MLD

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗